Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

Details

Serval ID
serval:BIB_6E08CDBE9844
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
Journal
European Journal of Internal Medicine
Author(s)
Groh M., Pagnoux C., Baldini C., Bel E., Bottero P., Cottin V., Dalhoff K., Dunogué B., Gross W., Holle J., Humbert M., Jayne D., Jennette J.C., Lazor R., Mahr A., Merkel P.A., Mouthon L., Sinico R.A., Specks U., Vaglio A., Wechsler M.E., Cordier J.F., Guillevin L.
ISSN
1879-0828 (Electronic)
ISSN-L
0953-6205
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
26
Number
7
Pages
545-553
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
OBJECTIVE: To develop disease-specific recommendations for the diagnosis and management of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) (EGPA).
METHODS: The EGPA Consensus Task Force experts comprised 8 pulmonologists, 6 internists, 4 rheumatologists, 3 nephrologists, 1 pathologist and 1 allergist from 5 European countries and the USA. Using a modified Delphi process, a list of 40 questions was elaborated by 2 members and sent to all participants prior to the meeting. Concurrently, an extensive literature search was undertaken with publications assigned with a level of evidence according to accepted criteria. Drafts of the recommendations were circulated for review to all members until final consensus was reached.
RESULTS: Twenty-two recommendations concerning the diagnosis, initial evaluation, treatment and monitoring of EGPA patients were established. The relevant published information on EGPA, antineutrophil-cytoplasm antibody-associated vasculitides, hypereosinophilic syndromes and eosinophilic asthma supporting these recommendations was also reviewed.
DISCUSSION: These recommendations aim to give physicians tools for effective and individual management of EGPA patients, and to provide guidance for further targeted research.
Keywords
Advisory Committees, Churg-Strauss Syndrome/diagnosis, Churg-Strauss Syndrome/drug therapy, Consensus, Disease Management, Europe, Glucocorticoids/therapeutic use, Granulomatosis with Polyangiitis/diagnosis, Granulomatosis with Polyangiitis/drug therapy, Humans, Immunosuppressive Agents/therapeutic use, Rituximab/therapeutic use, United States
Pubmed
Web of science
Open Access
Yes
Create date
03/01/2016 16:47
Last modification date
20/08/2019 14:27
Usage data